Industries > Pharma > Chinese Pharmaceutical Market Forecast 2017-2027

Chinese Pharmaceutical Market Forecast 2017-2027

Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics

PUBLISHED: 18 September 2017
PAGES: 253
PRODUCT CODE: PHA0238

Clear
WOOCS 2.2.1

The Chinese Pharmaceutical market is expected to grow at a CAGR of 12.3% in the second half of the forecast period. The Chinese Pharmaceutical market reached $145.4bn in 2016, dominated by the Cardiovascular therapy area which held 13.6% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 253-page report you will receive 68 tables and 90 figures– all unavailable elsewhere.

The 253-page report provides clear detailed insight into the Chinese Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Chinese Pharmaceutical Market Forecast 2017-2027

Report Scope

Chinese Pharmaceutical market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by therapy area:
– Cardiovascular: including specific revenue forecasts for Hypertension and Dyslipidaemia
– Anticancer
– Infectious Diseases
– Diabetes
– Respiratory:
including specific revenue forecasts for Asthma and COPD
– Central Nervous System:
including specific revenue forecasts for Antidepressants
– Autoimmune
– Others

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading product class:
– Small Molecules: further broken down into Generics Drugs and Branded Drugs
– Traditional Chinese Medicine
– Biologics: further broken down into Biologics (branded), Vaccines and Biosimilars

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading type of drug:
– Generic Prescription Drugs
– Over-the-Counter (OTC) Drugs
– Patented Prescription Drugs

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by sales channel:
– Hospitals
– Retail Pharmacies
– Grassroots Clinics

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.

• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT) that influence the Chinese Pharmaceutical Market. It also analyses social, technological, economic and political factors (STEP) that influence the Chinese Pharmaceutical Market

• Our study ranks and provides 2016 revenues as well as market share of the top 50 domestic Chinese Pharmaceutical companies and top 10 Multinational Pharmaceutical Companies that are the major players in the Chinese Pharmaceutical Market

• Our study lists and discusses the leading domestic and multinational Contract Research Organizations (CRO) that dominate the Chinese Pharmaceutical Market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Chinese Pharmaceutical market. You find data, trends and predictions.

Buy our report today Chinese Pharmaceutical Market Forecast 2017-2027: Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter (OTC) Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics, Domestic Pharmaceutical Companies, Multinational Pharmaceutical Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Chinese Pharmaceutical Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Chinese Pharmaceutical Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Biologics Market Report 2020-2030

Biosimilars will be changing the biologics market in the long term. But whether it does it for the better or the worse will depend on how the producers of biologics respond to their market presence.

06 August 2020

READ

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

READ

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

READ

Visiongain Publishes Advanced Wound Care Market Report 2020-2030

Traditional wound care such as gauze and compression therapies are less effective than active wound care products. Active wound dressings create an environment more suitable for healing.

03 August 2020

READ

Categories

Category